STOCK TITAN

[Form 4] Progress Software Corp (DE) Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 filing overview: On 07/02/2025, Zai Lab Ltd (ticker: ZLAB) granted its Chairperson & Chief Executive Officer, Du Ying, a new equity award in the form of 44,194 Restricted Share Units (RSUs). Each RSU converts into one American Depositary Share (ADS), and every ADS represents ten ordinary shares of the company.

Key terms of the award:

  • Vesting schedule: The RSUs vest in four equal annual tranches starting 07/02/2026 and ending 07/02/2029, contingent on continued service.
  • Cost basis: The grant price is reported as $0 because RSUs are awarded, not purchased.
  • Post-grant holdings: The filing shows 44,194 derivative securities (RSUs) beneficially owned directly by the reporting person after the transaction; no common ADS transactions were reported in Table I.

Investor takeaways: The award is a routine incentive grant that aligns top-management compensation with shareholder value creation over a multi-year horizon. There is no indication of share sales or disposals, so the transaction does not reflect profit-taking or a change in ownership intent. While the grant reinforces long-term alignment, it has no immediate cash flow or earnings impact and is unlikely to materially move the stock on its own.

Panoramica della dichiarazione Form 4: Il 02/07/2025, Zai Lab Ltd (simbolo: ZLAB) ha assegnato al suo Presidente e Amministratore Delegato, Du Ying, un nuovo premio azionario sotto forma di 44.194 Restricted Share Units (RSU). Ogni RSU si converte in un American Depositary Share (ADS), e ogni ADS rappresenta dieci azioni ordinarie della società.

Termini principali del premio:

  • Calendario di maturazione: Le RSU maturano in quattro tranche annuali uguali a partire dal 02/07/2026 fino al 02/07/2029, subordinatamente alla continuazione del servizio.
  • Base di costo: Il prezzo di assegnazione è indicato come $0 perché le RSU vengono assegnate e non acquistate.
  • Detenzioni post-assegnazione: La dichiarazione mostra 44.194 titoli derivati (RSU) detenuti direttamente a beneficio della persona che effettua la segnalazione dopo la transazione; non sono state riportate transazioni di ADS comuni nella Tabella I.

Considerazioni per gli investitori: Il premio rappresenta un incentivo di routine che allinea la remunerazione del top management con la creazione di valore per gli azionisti su un orizzonte pluriennale. Non vi è alcuna indicazione di vendite o cessioni di azioni, quindi la transazione non riflette una presa di profitto o un cambiamento nell’intento di possesso. Pur rafforzando l’allineamento a lungo termine, non ha impatto immediato sui flussi di cassa o sugli utili ed è improbabile che influenzi significativamente il titolo da solo.

Resumen del formulario 4: El 02/07/2025, Zai Lab Ltd (símbolo: ZLAB) otorgó a su Presidenta y Directora Ejecutiva, Du Ying, una nueva concesión de acciones en forma de 44,194 Unidades de Acciones Restringidas (RSUs). Cada RSU se convierte en una American Depositary Share (ADS), y cada ADS representa diez acciones ordinarias de la empresa.

Términos clave de la concesión:

  • Calendario de adquisición: Las RSUs se adquieren en cuatro cuotas anuales iguales desde el 02/07/2026 hasta el 02/07/2029, condicionado a la continuidad en el servicio.
  • Base de costo: El precio de la concesión se reporta como $0 porque las RSUs se otorgan, no se compran.
  • Participaciones posteriores a la concesión: El informe muestra 44,194 valores derivados (RSUs) en propiedad directa del informante después de la transacción; no se reportaron transacciones de ADS comunes en la Tabla I.

Conclusiones para inversores: La concesión es un incentivo rutinario que alinea la compensación de la alta dirección con la creación de valor para los accionistas a largo plazo. No hay indicios de ventas o disposiciones de acciones, por lo que la transacción no refleja toma de ganancias ni un cambio en la intención de propiedad. Aunque refuerza la alineación a largo plazo, no tiene impacto inmediato en flujo de caja ni en ganancias y es poco probable que mueva significativamente la acción por sí sola.

Form 4 제출 개요: 2025년 7월 2일, Zai Lab Ltd(티커: ZLAB)는 회장 겸 최고경영자인 Du Ying에게 44,194개의 제한부 주식 단위(RSU) 형태로 신규 주식 보상을 부여했습니다. 각 RSU는 하나의 미국 예탁 증서(ADS)로 전환되며, 한 ADS는 회사 보통주 10주를 나타냅니다.

보상 주요 조건:

  • 베스팅 일정: RSU는 2026년 7월 2일부터 2029년 7월 2일까지 4년에 걸쳐 매년 동일한 비율로 베스팅되며, 계속 근무 조건이 붙습니다.
  • 취득 원가: RSU는 구매가 아닌 부여 형식이므로 부여 가격은 $0으로 보고됩니다.
  • 부여 후 보유 현황: 제출 서류에는 거래 후 보고자 직접 소유하는 44,194개의 파생 증권(RSU)이 표시되며, 표 I에서는 보통 ADS 거래가 보고되지 않았습니다.

투자자 참고 사항: 이 보상은 최고 경영진 보수를 주주 가치 창출과 장기적으로 연계하는 일상적인 인센티브입니다. 주식 매도나 처분 징후는 없으며, 따라서 이 거래는 이익 실현이나 소유 의도 변경을 반영하지 않습니다. 장기적 연계는 강화하지만, 즉각적인 현금 흐름이나 수익 영향은 없으며 단독으로 주가에 큰 영향을 미치기 어렵습니다.

Résumé du dépôt du formulaire 4 : Le 02/07/2025, Zai Lab Ltd (symbole : ZLAB) a accordé à sa Présidente et Directrice Générale, Du Ying, une nouvelle attribution d’actions sous forme de 44 194 unités d’actions restreintes (RSU). Chaque RSU se convertit en une American Depositary Share (ADS), chaque ADS représentant dix actions ordinaires de la société.

Principaux termes de l’attribution :

  • Calendrier d’acquisition : Les RSU sont acquises en quatre tranches annuelles égales à partir du 02/07/2026 jusqu’au 02/07/2029, sous condition de maintien du service.
  • Base de coût : Le prix d’attribution est déclaré à 0 $ car les RSU sont attribuées et non achetées.
  • Détentions après attribution : Le dépôt indique que la personne déclarante détient directement 44 194 titres dérivés (RSU) après la transaction ; aucune transaction d’ADS ordinaires n’a été rapportée dans le tableau I.

Points clés pour les investisseurs : Cette attribution est une mesure incitative courante alignant la rémunération de la haute direction sur la création de valeur actionnariale sur plusieurs années. Il n’y a aucune indication de ventes ou de cessions d’actions, la transaction ne reflète donc ni prise de bénéfices ni changement d’intention de détention. Bien que cette attribution renforce l’alignement à long terme, elle n’a aucun impact immédiat sur les flux de trésorerie ou les résultats et est peu susceptible de faire bouger significativement le cours de l’action à elle seule.

Überblick über die Form 4-Meldung: Am 02.07.2025 gewährte Zai Lab Ltd (Ticker: ZLAB) seiner Vorsitzenden und Geschäftsführerin, Du Ying, eine neue Aktienzuteilung in Form von 44.194 Restricted Share Units (RSUs). Jede RSU wandelt sich in eine American Depositary Share (ADS) um, wobei jede ADS zehn Stammaktien des Unternehmens repräsentiert.

Wesentliche Bedingungen der Zuteilung:

  • Vesting-Zeitplan: Die RSUs werden in vier gleichen jährlichen Tranchen von 02.07.2026 bis 02.07.2029 unverfallbar, vorbehaltlich fortgesetzter Dienstzeit.
  • Kostenbasis: Der Zuteilungspreis wird mit $0 angegeben, da RSUs gewährt und nicht gekauft werden.
  • Bestände nach der Zuteilung: Die Meldung zeigt 44.194 derivative Wertpapiere (RSUs), die der meldenden Person nach der Transaktion direkt wirtschaftlich zustehen; keine Transaktionen mit regulären ADS wurden in Tabelle I gemeldet.

Fazit für Investoren: Die Zuteilung ist ein routinemäßiger Anreiz, der die Vergütung des Top-Managements mit der Wertschaffung für Aktionäre über mehrere Jahre hinweg in Einklang bringt. Es gibt keinen Hinweis auf Aktienverkäufe oder -veräußerungen, daher spiegelt die Transaktion weder Gewinnmitnahmen noch eine Änderung der Eigentumsabsicht wider. Obwohl die Zuteilung die langfristige Ausrichtung stärkt, hat sie keine unmittelbaren Auswirkungen auf Cashflow oder Gewinn und wird die Aktie allein wahrscheinlich nicht wesentlich bewegen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine RSU grant to CEO; no shares sold, neutral impact.

The 44,194-unit RSU grant to Chairperson & CEO Du Ying is standard annual equity compensation. Vesting over four years encourages retention and long-term value creation, but it does not alter outstanding share count until settled and is already contemplated in equity-based compensation plans. Absence of sales signals confidence, yet the transaction is not large enough relative to ZLAB’s float to be market-moving. Overall, the filing is informational with neutral investment impact.

Panoramica della dichiarazione Form 4: Il 02/07/2025, Zai Lab Ltd (simbolo: ZLAB) ha assegnato al suo Presidente e Amministratore Delegato, Du Ying, un nuovo premio azionario sotto forma di 44.194 Restricted Share Units (RSU). Ogni RSU si converte in un American Depositary Share (ADS), e ogni ADS rappresenta dieci azioni ordinarie della società.

Termini principali del premio:

  • Calendario di maturazione: Le RSU maturano in quattro tranche annuali uguali a partire dal 02/07/2026 fino al 02/07/2029, subordinatamente alla continuazione del servizio.
  • Base di costo: Il prezzo di assegnazione è indicato come $0 perché le RSU vengono assegnate e non acquistate.
  • Detenzioni post-assegnazione: La dichiarazione mostra 44.194 titoli derivati (RSU) detenuti direttamente a beneficio della persona che effettua la segnalazione dopo la transazione; non sono state riportate transazioni di ADS comuni nella Tabella I.

Considerazioni per gli investitori: Il premio rappresenta un incentivo di routine che allinea la remunerazione del top management con la creazione di valore per gli azionisti su un orizzonte pluriennale. Non vi è alcuna indicazione di vendite o cessioni di azioni, quindi la transazione non riflette una presa di profitto o un cambiamento nell’intento di possesso. Pur rafforzando l’allineamento a lungo termine, non ha impatto immediato sui flussi di cassa o sugli utili ed è improbabile che influenzi significativamente il titolo da solo.

Resumen del formulario 4: El 02/07/2025, Zai Lab Ltd (símbolo: ZLAB) otorgó a su Presidenta y Directora Ejecutiva, Du Ying, una nueva concesión de acciones en forma de 44,194 Unidades de Acciones Restringidas (RSUs). Cada RSU se convierte en una American Depositary Share (ADS), y cada ADS representa diez acciones ordinarias de la empresa.

Términos clave de la concesión:

  • Calendario de adquisición: Las RSUs se adquieren en cuatro cuotas anuales iguales desde el 02/07/2026 hasta el 02/07/2029, condicionado a la continuidad en el servicio.
  • Base de costo: El precio de la concesión se reporta como $0 porque las RSUs se otorgan, no se compran.
  • Participaciones posteriores a la concesión: El informe muestra 44,194 valores derivados (RSUs) en propiedad directa del informante después de la transacción; no se reportaron transacciones de ADS comunes en la Tabla I.

Conclusiones para inversores: La concesión es un incentivo rutinario que alinea la compensación de la alta dirección con la creación de valor para los accionistas a largo plazo. No hay indicios de ventas o disposiciones de acciones, por lo que la transacción no refleja toma de ganancias ni un cambio en la intención de propiedad. Aunque refuerza la alineación a largo plazo, no tiene impacto inmediato en flujo de caja ni en ganancias y es poco probable que mueva significativamente la acción por sí sola.

Form 4 제출 개요: 2025년 7월 2일, Zai Lab Ltd(티커: ZLAB)는 회장 겸 최고경영자인 Du Ying에게 44,194개의 제한부 주식 단위(RSU) 형태로 신규 주식 보상을 부여했습니다. 각 RSU는 하나의 미국 예탁 증서(ADS)로 전환되며, 한 ADS는 회사 보통주 10주를 나타냅니다.

보상 주요 조건:

  • 베스팅 일정: RSU는 2026년 7월 2일부터 2029년 7월 2일까지 4년에 걸쳐 매년 동일한 비율로 베스팅되며, 계속 근무 조건이 붙습니다.
  • 취득 원가: RSU는 구매가 아닌 부여 형식이므로 부여 가격은 $0으로 보고됩니다.
  • 부여 후 보유 현황: 제출 서류에는 거래 후 보고자 직접 소유하는 44,194개의 파생 증권(RSU)이 표시되며, 표 I에서는 보통 ADS 거래가 보고되지 않았습니다.

투자자 참고 사항: 이 보상은 최고 경영진 보수를 주주 가치 창출과 장기적으로 연계하는 일상적인 인센티브입니다. 주식 매도나 처분 징후는 없으며, 따라서 이 거래는 이익 실현이나 소유 의도 변경을 반영하지 않습니다. 장기적 연계는 강화하지만, 즉각적인 현금 흐름이나 수익 영향은 없으며 단독으로 주가에 큰 영향을 미치기 어렵습니다.

Résumé du dépôt du formulaire 4 : Le 02/07/2025, Zai Lab Ltd (symbole : ZLAB) a accordé à sa Présidente et Directrice Générale, Du Ying, une nouvelle attribution d’actions sous forme de 44 194 unités d’actions restreintes (RSU). Chaque RSU se convertit en une American Depositary Share (ADS), chaque ADS représentant dix actions ordinaires de la société.

Principaux termes de l’attribution :

  • Calendrier d’acquisition : Les RSU sont acquises en quatre tranches annuelles égales à partir du 02/07/2026 jusqu’au 02/07/2029, sous condition de maintien du service.
  • Base de coût : Le prix d’attribution est déclaré à 0 $ car les RSU sont attribuées et non achetées.
  • Détentions après attribution : Le dépôt indique que la personne déclarante détient directement 44 194 titres dérivés (RSU) après la transaction ; aucune transaction d’ADS ordinaires n’a été rapportée dans le tableau I.

Points clés pour les investisseurs : Cette attribution est une mesure incitative courante alignant la rémunération de la haute direction sur la création de valeur actionnariale sur plusieurs années. Il n’y a aucune indication de ventes ou de cessions d’actions, la transaction ne reflète donc ni prise de bénéfices ni changement d’intention de détention. Bien que cette attribution renforce l’alignement à long terme, elle n’a aucun impact immédiat sur les flux de trésorerie ou les résultats et est peu susceptible de faire bouger significativement le cours de l’action à elle seule.

Überblick über die Form 4-Meldung: Am 02.07.2025 gewährte Zai Lab Ltd (Ticker: ZLAB) seiner Vorsitzenden und Geschäftsführerin, Du Ying, eine neue Aktienzuteilung in Form von 44.194 Restricted Share Units (RSUs). Jede RSU wandelt sich in eine American Depositary Share (ADS) um, wobei jede ADS zehn Stammaktien des Unternehmens repräsentiert.

Wesentliche Bedingungen der Zuteilung:

  • Vesting-Zeitplan: Die RSUs werden in vier gleichen jährlichen Tranchen von 02.07.2026 bis 02.07.2029 unverfallbar, vorbehaltlich fortgesetzter Dienstzeit.
  • Kostenbasis: Der Zuteilungspreis wird mit $0 angegeben, da RSUs gewährt und nicht gekauft werden.
  • Bestände nach der Zuteilung: Die Meldung zeigt 44.194 derivative Wertpapiere (RSUs), die der meldenden Person nach der Transaktion direkt wirtschaftlich zustehen; keine Transaktionen mit regulären ADS wurden in Tabelle I gemeldet.

Fazit für Investoren: Die Zuteilung ist ein routinemäßiger Anreiz, der die Vergütung des Top-Managements mit der Wertschaffung für Aktionäre über mehrere Jahre hinweg in Einklang bringt. Es gibt keinen Hinweis auf Aktienverkäufe oder -veräußerungen, daher spiegelt die Transaktion weder Gewinnmitnahmen noch eine Änderung der Eigentumsabsicht wider. Obwohl die Zuteilung die langfristige Ausrichtung stärkt, hat sie keine unmittelbaren Auswirkungen auf Cashflow oder Gewinn und wird die Aktie allein wahrscheinlich nicht wesentlich bewegen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KRALL DAVID

(Last) (First) (Middle)
C/O PROGRESS SOFTWARE CORPORATION
15 WAYSIDE ROAD, SUITE 400

(Street)
BURLINGTON MA 01803

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PROGRESS SOFTWARE CORP /MA [ PRGS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2025 A 4,175(1) A $53.9 94,965 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents deferred stock units issued to the Reporting Person by Progress Software Corporation (the "Company") as the fiscal year 2025 equity retainer for the Reporting Person's services as a director of the Company during such period. These deferred stock units were issued in accordance with the Company's Director Compensation Plan pursuant to the Company's 2008 Stock Option and Incentive Plan and are payable on a one-for-one basis exclusively in common stock on the earlier of a change in control of the Company or the date the Reporting Person terminates service on the board of directors of the Company (the "Board of Directors"). The deferred stock units will vest on the date of the Company's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors until such date.
Remarks:
YuFan Stephanie Wang, Attorney-in-Fact 07/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ZLAB RSUs were granted to CEO Du Ying on 07/02/2025?

The filing reports 44,194 Restricted Share Units were granted.

When will the newly granted ZLAB RSUs vest?

They vest in four equal annual installments beginning 07/02/2026.

Did the CEO sell any ZLAB shares in this Form 4?

No. No ADS sales or disposals are reported; only an acquisition of RSUs.

What does each ZLAB ADS represent according to the filing?

Each ADS represents ten ordinary shares of Zai Lab Ltd.

Does this RSU grant affect ZLAB’s earnings or cash flow?

The grant is non-cash; it increases stock-based compensation expense over time but has no immediate cash flow impact.
Progress Soft

NASDAQ:PRGS

PRGS Rankings

PRGS Latest News

PRGS Latest SEC Filings

PRGS Stock Data

2.35B
42.32M
1.49%
117.97%
12.27%
Software - Infrastructure
Services-prepackaged Software
Link
United States
BURLINGTON